Preview

Current Pediatrics

Advanced search

APPLICATION EXPERIENCE OF CETIRIZINE IN THERAPY AGAINST ALLERGIC DERMATOSES AMONG CHILDREN

Abstract

The authors highlight the application experience of cetirizine (Parlazin, Egis, Hungary) among 27 children aged between 3 and 17 years, suffering from hives, allergic dermatitis (common and contact), atopic dermatitis and associated respiratory allergy presentations. They showed the clinical efficiency of a medication and its good tolerance.
Key words: cetirizine, allergic dermatitis, atopic dermatitis, children, treatment.

About the Authors

I.M. Korsunskaya
Center for Theoretical Problems of Physical Chemical Pharmacology, Russian Academy of Sciences, Moscow
Russian Federation



A.B. Zakharova
Center for Theoretical Problems of Physical Chemical Pharmacology, Russian Academy of Sciences, Moscow
Russian Federation


E.V. Zhavoronkova
Center for Theoretical Problems of Physical Chemical Pharmacology, Russian Academy of Sciences, Moscow
Russian Federation



S.S. Zelentsova
Center for Theoretical Problems of Physical Chemical Pharmacology, Russian Academy of Sciences, Moscow
Russian Federation


Z. Nevozinskaya
Center for Theoretical Problems of Physical Chemical Pharmacology, Russian Academy of Sciences, Moscow
Russian Federation


References

1. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт. 1998. 251 с.

2. Емельянов А.В. Крапивница и отёк Квинке. СПб. 2002. 28 с.

3. Ревякина В.А. Иммунологические основы развития атопического дерматита и новая стратегия терапии. Соnsilium Medicum. Педиатрия. 2004; (Прил. 1): 31–33.

4. Скрипкин Ю.К., Зверькова Ф.А., Шарапова Г.Я., Студницин А.А. Руководство по детской дерматологии. М.: Медицина. 1988. С. 250–2544.

5. Филатова Т.А., Ревякина В.А., Кондюрина Е.Г., Зеленская В.В. Парлазин в лечении атопического дерматита у детей. Вопросы современной педиатрии. 2005; 4 (2): 20–22.

6. Diepgen T.L. Early Treatment of the Atopic Child Study Group Long term treatment with cetirizine of infants with atopic dermatitis: a multi country, double blind, randomized, placebo controlled trial (the ETAC trial) over 18 months. Pediatr. Allergy Immunol. 2002; 13 (4): 278–286.

7. Cetirizine. Ann. Allergy. 1987; 59: 4–8.

8. Pecquet C., Bayrou O., Vuong T.M., Huet S. et al. Familial aquagenic urticaria. Abstract of 20th World Congress of Dermatology. Paris. 2002. Abs. № Р 2308.

9. Stevenson J., Cornah D., Evrard P. et al. LongCterm evaluation of the impact of the H1Creceptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis. Pediatr. Res. 2002; 52 (2): 251–257.

10. Wuthrich B. Clinical aspects, epidemiology and prognosis of atopic eczema. Ann. Allergy Asthma Immunol. 1999; 83: 464–470.


Review

For citations:


Korsunskaya I., Zakharova A., Zhavoronkova E., Zelentsova S., Nevozinskaya Z. APPLICATION EXPERIENCE OF CETIRIZINE IN THERAPY AGAINST ALLERGIC DERMATOSES AMONG CHILDREN. Current Pediatrics. 2007;6(2):136-138.

Views: 603


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)